Identification, Heterologous Expression, and Characterization of the Tolypodiol Biosynthetic Gene Cluster through an Integrated Approach
ACS Chemical Biology · 18.08.2023 · 18 (8) · 1797-1807
DOI: 10.1021/acschembio.3c00225 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 24.07.2023. Verfasst von Daniel Back und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331, United States. Hauptthemen laut MEDLINE: Biological Products, Diterpenes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Cyanobacteria are tremendous producers of biologically active natural products, including the potent anti-inflammatory compound tolypodiol. However, linking biosynthetic gene clusters with compound production in cyanobacteria has lagged behind that in other bacterial genera. Tolypodiol is a meroterpenoid originally isolated from the cyanobacterium HT-58-2. Here we describe the identification of the tolypodiol biosynthetic gene cluster through heterologous expression in Anabaena and in vitro protein assays of a methyltransferase found in the tolypodiol biosynthetic gene cluster. We have also identified similar biosynthetic gene clusters in cyanobacterial and actinobacterial genomes, suggesting that meroterpenoids with structural similarity to the tolypodiols may be synthesized by other microbes. We also report the identification of two new analogs of tolypodiol that we have identified in both the original and heterologous producer. This work further illustrates the usefulness of Anabaena as a heterologous expression host for cyanobacterial compounds and how integrated approaches can help to link natural product compounds with their producing biosynthetic gene clusters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331, United States.
- Department of Chemistry, University of Hawai'i at Ma̅noa, Honolulu, Hawaii 96822, United States.
- Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331, United States.
ORCID-Profile: Philip G Williams, Benjamin Philmus
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
- NIH HHS
- NCCIH NIH HHS
- Division of Chemistry
- Elsa U. Pardee Foundation
- M.J. Murdock Charitable Trust
- National Center for Complementary and Integrative Health
Zitieren
APA
Back, D., O'Donnell, T. J., Axt, K. K., Gurr, J. R., Vanegas, J. M., Williams, P. G., & Philmus, B. (2023). Identification, Heterologous Expression, and Characterization of the Tolypodiol Biosynthetic Gene Cluster through an Integrated Approach. ACS Chemical Biology, 18(8), 1797-1807. https://doi.org/10.1021/acschembio.3c00225
Vancouver
Back D, O'Donnell TJ, Axt KK, Gurr JR, Vanegas JM, Williams PG, et al. Identification, Heterologous Expression, and Characterization of the Tolypodiol Biosynthetic Gene Cluster through an Integrated Approach. ACS Chemical Biology. 2023;18(8):1797-1807. doi:10.1021/acschembio.3c00225
BibTeX
@article{Back2023,
author = {Back, Daniel and O'Donnell, Timothy J and Axt, Kyle K and Gurr, Joshua R and Vanegas, Juan M and Williams, Philip G and Philmus, Benjamin},
title = {Identification, Heterologous Expression, and Characterization of the Tolypodiol Biosynthetic Gene Cluster through an Integrated Approach},
journal = {ACS Chemical Biology},
year = {2023},
volume = {18},
number = {8},
pages = {1797--1807},
doi = {10.1021/acschembio.3c00225}
}
EUVIMED